In fact, docs say that there are a few common symptoms that patients show up concerned about—only for them to be totally fine ...
Kozhikode: A 52-year-old woman, weighing around 93–94 kg, assumed her heavy monthly bleeding and abdominal discomfort were ...
Tia Lee, a young professional working four jobs alongside her full-time role, pushed herself into a severe health crisis while chasing career success. Constant travel, stress, and overwork led to ...
Tia Lee Fowlkes worked four simultaneous jobs to achieve her idea of success: a stacked bank account. Stressed and overworked ...
Abstract: Colorectal cancer stands out as a major factor in cancer-related fatalities. The prevention of colorectal cancer may be aided by early polyp diagnosis. Colonoscopy is a widely used procedure ...
College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu 225009, P. R. China Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, ...
From Roche’s $1.4 billion licensing deal to AstraZeneca’s presidential symposium and an avalanche of clinical readouts, antibody-drug conjugates dominated Europe’s leading cancer conference over the ...
Tezspire (tezepelumab-ekko) is a prescription medicine used to treat inflammatory conditions of the airways, such as severe asthma. The FDA has now approved it as an add-on treatment for adults and ...
Tezepelumab-ekko is now approved for chronic rhinosinusitis with nasal polyps (CRSwNP), targeting thymic stromal lymphopoietin and marking its second indication after severe asthma. The phase 3 ...
Experts say the uterus does not change size during menstruation. Bloating and heaviness are caused by hormonal fluctuations and water retention. You’ve probably noticed that your body feels heavier ...
Six years since the FDA blessed Sanofi and Regeneron’s Dupixent as the first biologic to treat chronic rhinosinusitis with nasal polyps (CRSwNP), a second biologic therapy has broken through with a ...
Please provide your email address to receive an email when new articles are posted on . The FDA on Friday approved a new biologic as add-on maintenance treatment for inadequately controlled chronic ...